Paquette et al. showed that PBMCs obtained from CML patients could be differentiated into dendritic cells by adding IFN-α and GM-CSF with subsequent proliferation of T cells [76]. The gene discussed is CSF2; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.